hDSG2

Nomenclature

C57BL/6JSmo-Dsg2tm1(hDSG2)Smoc

Cat. NO.

NM-HU-241088

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
Dsg2

Model Description

The endogenous mouse Dsg2 gene was replaced by human DSG2 gene.

Validation Data

image.png

Fig.1 Detection of mouse Dsg2 expression in lung and colon by RT-PCR. Mouse Dsg2 mRNA (314 bp) was detectable only in wild-type C57BL/6 mice. Total RNA of lung and colon tissues was extracted from 6-week-old male wild-type C57BL/6 (WT)(n=3) and homozygous hDSG2 knockin mice (HO) (n=3), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers. 

Abbr. M, marker; HO, homozygous; WT, wild type.

image.png

Fig.2 Detection of human DSG2 expression in heart, lung, brain, stomach, colon and pancreas by RT-PCR. Human DSG2 mRNA (101 bp) was detectable only in homozygous hDSG2 knockin mice but not in wild-type mice. Heart, lung, brain, stomach, colon and pancreas RNA was extracted from 6-week-old male wild-type C57BL/6 (WT)(n=3) and homozygous hDSG2 knockin mice (HO) (n=3), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers. 

Abbr. M, marker; HO, homozygous; WT, wild type.

image.png

Fig.3 Detection of DSG2 expression in hDSG2 mice by WB. DSG2 was detectable in lung, heart, colon, stomach, pancreas and brain from both WT C57BL/6 and homozygous hDSG2 mice, as the antibody was cross-reactived between human and mouse DSG2. The lung, heart, colon, stomach, pancreas and brain tissue lysates were collected from 6-week-old male wild-type C57BL/6 mice and 6-week-old male homozygous hDSG2 mice, and then analyzed by western blot with anti-DSG2 antibody. Arrows showed the full-length DSG2 protein and stars showed the cleaved DSG2 protein.

Abbr. HO, homozygous; WT, wild type; PC, positive control, HepG2 cells.


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more